William J. Addicks
Pharmacy in Morgantown, WV
License number
West Virginia A1-0002463
Issued Date
Mar 11, 1992
Expiration Date
Sep 30, 2018
Category
Pharmacy
Type
Pharmacist
Address
Address
2
Morgantown, WV 26505
Professional information
Phenytoin Sodium Pharmaceutical Compositions
US Patent:
6620432, Sep 16, 2003
Filed:
May 11, 2001
Appl. No.:
09/852761
Inventors:
William J. Addicks - Morgantown WV
Joseph P. Duda - Morgantown WV
Daniel A. Snider - Morgantown WV
Kerry R. Benson - Morgantown WV
Joseph P. Duda - Morgantown WV
Daniel A. Snider - Morgantown WV
Kerry R. Benson - Morgantown WV
Assignee:
Mylan Pharmaceuticals Inc. - Morgantown WV
International Classification:
A61K 920
US Classification:
424451, 424464, 424484, 424485, 424486, 424487, 424488, 424469, 514770, 5147723, 514773, 514774, 514777, 514778, 514779, 514781, 514782, 514783
Abstract:
A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.
Extended Release Formulation Containing A Wax
US Patent:
2009023, Sep 24, 2009
Filed:
Mar 18, 2009
Appl. No.:
12/406272
Inventors:
Sarat C. Chattaraj - Morgantown WV, US
Pavan Bhat - Morgantown WV, US
Glenn A. Redelman - Morgantown WV, US
David J. Wargo - Pittsburgh PA, US
William Addicks - Morgantown WV, US
Pavan Bhat - Morgantown WV, US
Glenn A. Redelman - Morgantown WV, US
David J. Wargo - Pittsburgh PA, US
William Addicks - Morgantown WV, US
Assignee:
Mylan Pharmaceuticals, Inc. - Morgantown WV
International Classification:
A61K 9/10, A61K 31/496, A61K 9/14
US Classification:
424484, 51425308, 424502
Abstract:
Extended release pharmaceutical formulations are disclosed wherein the formulations contain an extended release portion and an immediate release portion, the extended release portion comprising an active pharmaceutical ingredient and a wax. Methods of making such extended release pharmaceutical formulations are also disclosed.
Phenytoin Sodium Pharmaceutical Compositions
US Patent:
6274168, Aug 14, 2001
Filed:
Feb 23, 1999
Appl. No.:
9/255705
Inventors:
William J Addicks - Morgantown WV
Joseph P Duda - Morgantown WV
Daniel A. Snider - Morgantown WV
Kerry R Benson - Morgantown WV
Joseph P Duda - Morgantown WV
Daniel A. Snider - Morgantown WV
Kerry R Benson - Morgantown WV
Assignee:
Mylan Pharmaceuticals Inc. - Morgantown WV
International Classification:
A61K 920, A61K 948, A61K 916
US Classification:
424451
Abstract:
A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.
Pharmaceutical Compositions Using Thiazepine
US Patent:
5948437, Sep 7, 1999
Filed:
May 28, 1997
Appl. No.:
8/864306
Inventors:
Bhavnish Vinod Parikh - Hockessin DE
Robert Joseph Timko - West Chester PA
William Joseph Addicks - Morgantown WV
Robert Joseph Timko - West Chester PA
William Joseph Addicks - Morgantown WV
Assignee:
Zeneca Limited
International Classification:
A61K 920
US Classification:
424464
Abstract:
The invention relates to sustained release formulations comprising 11-�4-�2-(2-hydroxyethoxy)ethyl!-1-piperazinyl!dibenzo�b,f! �1,4!thiazepine or a pharmaceutically acceptable salt thereof, to methods of treating psychotic states and hyperactivity utilizing the sustained release formulations and to a process for preparing the sustained release formulations.